超碰97人人射妻,日韩欧美在线综合网,精品国产亚洲一区二区三区,欲妇荡岳丰满少妇A片24小时

2023-10-17

【Explore the future of the pharmaceutical industry】 Kingfriend will meet you in CPHI Barcelona!

Return

Previous Nothing at all Next Kindos creates the new record for fastest approval by FDA: Dacarbazine for Injection

Relevant recommendations

2025-08-04

NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
2025-07-21

NKF makes its debut at CPHI Southeast Asia
2025-07-14

King-Friend will meet you in CPHI Malaysia！
2025-06-09

NKF's subsidiary Kindos's Hydralazine Hydrochloride Injection gets FDA approval for marketing
2025-05-26

NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing

Stock price

11.040

-0.050000000000001

?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd蘇ICP備13012010號